Synergy between TGF-β3 and NT-3 to promote the survival of spiral ganglia neurones in vitro

Neuroscience Letters

Volumn 240, Issue 2, 1998, Pages 77-80

  Marzella, P L ^a   Clark, G M ^a   Shepherd, R K ^a   Bartlett, P F ^b   Kilpatrick, T J ^b  

^a ROYAL VICTORIAN EYE AND EAR HOSPITAL   (Australia)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Auditory neurones; Cytokine; Neuronal degeneration; Neurotrophic effects; Neurotrophin; Pharmacological therapy

Indexed keywords

NEUROTROPHIN 3; TRANSFORMING GROWTH FACTOR BETA3;

ANIMAL CELL; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; NERVE CELL; NERVE CELL CULTURE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SPIRAL GANGLION;

EID: 0032498164     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)00928-2     Document Type: Article

References (20)

1. Buchman V.L., Sporn M., Davies A.M. Role of transforming growth factor-β isoforms in regulating the expression of nerve growth factor and neurotrophin-3 mRNA levels in embryonic cutaneous cells at different stages of development. Development. 120:1994;1621-1629.
2. Frenz D.A., Galinovic-Schwartz V., Liu W., Flanders K.C., Van de Water T.R. Transforming growth factor β1 is an epithelial-derived signal peptide that influences otic capsule formation. Dev. Biol. 153:1992;324-336.
3. Gouin A., Blochgallego E., Tanaka H., Rosenthal A., Henderson C.E. Transforming growth factor β3, glial cell line-derived neurotrophic factor, and fibroblast growth factor-2, act in a different manner to promote motorneuron survival in vitro. J. Neurosci. Res. 43:1996;454-464.
4. Houle J.H., Hui Ye J., Kane C.M. Axonal regeneration by chronically injured supraspinal neurons can be enhanced by exposure to insulin-like growth factor, b fibroblast growth factor or transforming growth factor β Restor. Neurol. Neurosci. 10:1996;205-215.
5. Kaartinen V., Voncken J.W., Shuler C., Warburton D., Bu D., Heisterkamp N., Groffen J. Abnormal lung development and cleft palate in mice lacking TGF-β3 indicates defects of epithelial-mesenchymal interaction. Nat. Genet. 11:1995;415-421.
6. Krieglstein K., Maysinger D., Unsicker K. The survival response of mesencephalic dopaminergic neurons to the neurotrophins BDNF and NT-4 requires priming with serum - comparison with members of the TGF-β superfamily and characterisation of the serum free culture system. J. Neural Transm. 47:1996;247-258.
7. Krieglstein K., Unsicker K. Distinct modulatory actions of TGF-β and LIF on neurotrophin-mediated survival of developing sensory neurons. Neurochem. Res. 21:1996;843-850.
8. Laping N.J., Morgan T.E., Nichols N.R., Rozovsky I., Young-Chan C.S., Zarow C., Finch C.E. Transforming growth factor β1 induces neuronal and astrocyte genes: tubulin α1, glial fibrillary acidic protein and clusterin. Neuroscience. 58:1994;563-572.
9. Lefebvre P.P., Martin D., Staecker H., Weber J.T., Moonen G., Van de Water T.R. TGF β1 expression is initiated in adult auditory neurons by sectioning of the auditory nerve. NeuroReport. 3:1992;295-298.
10. Lefebvre P.P., Weber J.T., Van de Water T.R., Rogister B., Moonen G. TGF-β1 modulates bFGF receptor message expression in cultured adult auditory neurons. NeuroReport. 2:1991;305-308.
11. Maness L.M., Weber J.T., Banks W.A., Beckman B.S., Zadina J.E. The neurotrophins and their receptors: structure function and neuropathology. Neurosci. Behav. Rev. 18:1994;143-159.
12. Marzella P.L., Clark G.M., Shepherd R.K., Bartlett P.F., Kilpatrick T.J. LIF potentiates the NT-3 mediated survival of spiral ganglia neurones in vitro. NeuroReport. 8:1997;1641-1644.
13. Messague, J., Heino, J. and Laiho, M., Mechanism in TGF-β action. In G. Bock and J. Marsh (Eds.), Transforming Growth Factors - Therapeutic Use, Ciba Foundation, Wiley, London, 1991, pp. 51-65.
14. Millan, F.A., Denhez, F., Kondaiah, P. and Akhurts, R.J., Embryonic gene expression patterns of TGF β1, β2 and β3 suggest different developmental function in vivo, Development, 111 (1991) 131-143.
15. Pelton R.W., Saxena B., Jones M., Moses H.L., Gold L.I. Immunohistochemical localisation on TGF β1, TGF β2 and TGF β3 in the mouse embryo: expression patterns suggests multiple roles during embryonic development. J. Cell Biol. 115:1991;1091-1105.
16. Roberts, A.B. and Sporn, M.B., The transforming growth factor-βs. In M.B. Sporn and A.B. Roberts (Eds.), Handbook of Experimental Pharmacology, Vol. 95/I, Springer-Verlag, Heidelberg, 1990, pp. 419-472.
17. Segarini, P.R., TGF β receptors. In G. Bock and J. Marsh (Eds.), Transforming Growth Factors - Therapeutic Use, Ciba Foundation, Wiley, London, 1991, pp. 29-50.
18. Staecker H., Kopke R., Malgrange B., Lefebvre P., Van de Water T. NT-3 and/or BDNF therapy prevents loss of auditory neurons following loss of hair cells. NeuroReport. 7:1996;889-894.
19. Van de Water T.R., Li C.W., Ruben R.J., Shea C.A. Ontogenic aspects of mammalian inner ear development. Birth Defects, Orig. Artic. Ser. 16:1980;5-45.
20. Zheng J.L., Gao W.Q. Differential damage to auditory neurons and hair cells by ototoxins and neuroprotection by specific neurotrophins in rat cochlear organotypic cultures. Eur. J. Neurosci. 8:1996;1897-1905.